InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Jones Andrew D., Chief Financial Officer. Insider active across 1 companies, notably NovaBay Pharmaceuticals, Inc.. Cumulatively, 4 filings have been published. Total volume traded: €7k. The latest transaction was disclosed on 3 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations4 total
€3,3828,690 shares@ €0.38920.0065% mcap6.2% of flow
Common Stock
SEC:0001437749-21-027933·
Ideal exit: 30 Aug 2022 (T+270)
€3,3828,690 shares@ €0.38920.0065% mcap3.1% of flow
Common Stock
SEC:0001437749-21-027933:0·
Ideal exit: 30 Aug 2022 (T+270)
€51,46477,994 shares@ €0.65980.099% mcap93.8% of flow
Common Stock
SEC:0001437749-21-011378·
€51,46477,994 shares@ €0.65980.099% mcap46.9% of flow
Common Stock
SEC:0001437749-21-011378:0·
4 of 4 declarations
About Jones Andrew D.
Andrew D. Jones is the CFO at NovaBay Pharmaceuticals, Inc. In this role, he is responsible for the financial management of the company, including financial planning and risk management. His expertise is essential for ensuring the economic health of NovaBay.
